Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mansoor Husain

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Diabetes|May 22, 2016
Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in DiabetesMeghan Sauvé, Sonya K Hui, Danny D Dinh, et al.
Communications Biology|May 13, 2020
Functional culture and in vitro genetic and small-molecule manipulation of adult mouse cardiomyocytesNeal I Callaghan, Shin-Haw Lee, Sina Hadipour-Lakmehsari, et al.
Circulation|November 29, 2012
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesityMohammad Hossein Noyan-Ashraf, Eric Akihiko Shikatani, Irmgard Schuiki, et al.
Circulation Research|July 31, 2010
Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstrictionJudith Hoefer, M Ali Azam, Jeffrey T E Kroetsch, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2017
HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent mannerKristina K Durham, Kevin M Chathely, Kei Cheng Mak, et al.
Journal of the American College of Cardiology|March 14, 2020
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart FailureSteven P Marso, Florian M M Baeres, Stephen C Bain, et al.
Cardiovascular Research|August 24, 2011
Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stressMirjana Jerkic, Mohammed G Kabir, Adrienne Davies, et al.
Diabetes|January 20, 2009
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in miceMohammad Hossein Noyan-Ashraf, M Abdul Momen, Kiwon Ban, et al.
Journal of the American Heart Association|January 25, 2023
Cardioprotective Actions of a Glucagon-like Peptide-1 Receptor Agonist on Hearts Donated After Circulatory DeathSachiko Kadowaki, M Ahsan Siraj, Weiden Chen, et al.
American Journal of Physiology. Renal Physiology|April 7, 2017
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Diabetes|May 22, 2016
Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in DiabetesMeghan Sauvé, Sonya K Hui, Danny D Dinh, et al.
Communications Biology|May 13, 2020
Functional culture and in vitro genetic and small-molecule manipulation of adult mouse cardiomyocytesNeal I Callaghan, Shin-Haw Lee, Sina Hadipour-Lakmehsari, et al.
Circulation|November 29, 2012
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesityMohammad Hossein Noyan-Ashraf, Eric Akihiko Shikatani, Irmgard Schuiki, et al.
Circulation Research|July 31, 2010
Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstrictionJudith Hoefer, M Ali Azam, Jeffrey T E Kroetsch, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2017
HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent mannerKristina K Durham, Kevin M Chathely, Kei Cheng Mak, et al.
Journal of the American College of Cardiology|March 14, 2020
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart FailureSteven P Marso, Florian M M Baeres, Stephen C Bain, et al.
Cardiovascular Research|August 24, 2011
Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stressMirjana Jerkic, Mohammed G Kabir, Adrienne Davies, et al.
Diabetes|January 20, 2009
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in miceMohammad Hossein Noyan-Ashraf, M Abdul Momen, Kiwon Ban, et al.
Journal of the American Heart Association|January 25, 2023
Cardioprotective Actions of a Glucagon-like Peptide-1 Receptor Agonist on Hearts Donated After Circulatory DeathSachiko Kadowaki, M Ahsan Siraj, Weiden Chen, et al.
American Journal of Physiology. Renal Physiology|April 7, 2017
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Pageof 14